Scarica l'app Stockscreener
24.69
6.84%
1.58
Dopo l'orario di chiusura:
24.69
Ceribell Inc Borsa (CBLL) Ultime notizie
CeriBell Inc expected to post a loss of 32 cents a shareEarnings Preview - TradingView
CeriBell: A Leader In AI-Powered Seizure Detection (NASDAQ:CBLL) - Seeking Alpha
CeriBell (CBLL) to Release Earnings on Tuesday - MarketBeat
Ceribell to Participate in the 45th Annual TD Cowen Healthcare Conference - GlobeNewswire
CeriBell (NASDAQ:CBLL) Receives $32.60 Average Target Price from Analysts - MarketBeat
CeriBell (NASDAQ:CBLL) Receives $32.60 Average Price Target from Brokerages - Defense World
Ceribell to Report Fourth Quarter and Full Year 2024 Financial Results on February 25, 2025 - GlobeNewswire
CeriBell, Inc. to Announce Q4 and Full Year 2024 Financial Results on February 25, 2025 - Nasdaq
CeriBell (CBLL) Expected to Announce Quarterly Earnings on Tuesday - Defense World
CeriBell (CBLL) Projected to Post Quarterly Earnings on Tuesday - MarketBeat
Nexalin Technology (NASDAQ:NXL) vs. CeriBell (NASDAQ:CBLL) Head-To-Head Contrast - Defense World
CeriBell (NASDAQ:CBLL) Trading 9.1% HigherShould You Buy? - MarketBeat
Beta Bionics targets up to $616 mln valuation in US IPO - Reuters
CeriBell (NASDAQ:CBLL) Receives $32.60 Consensus Price Target from Analysts - Defense World
Brokerages Set CeriBell (NASDAQ:CBLL) Price Target at $32.60 - MarketBeat
Ceribell Expands its Executive Management Team by Two - MPO-mag
CeriBell (NASDAQ:CBLL) Hits New 52-Week LowTime to Sell? - MarketBeat
CeriBell (NASDAQ:CBLL) Shares Down 9.2%Should You Sell? - MarketBeat
CeriBell (NASDAQ:CBLL) Trading Down 3.3%What's Next? - MarketBeat
Contrasting CeriBell (NASDAQ:CBLL) & Cutera (NASDAQ:CUTR) - Defense World
CeriBell Shares Rise 47% to Lead Trio of Life Sciences IPOs - MSN
CeriBell (NASDAQ:CBLL) Receives $32.60 Consensus PT from Analysts - Defense World
Head to Head Contrast: CeriBell (NASDAQ:CBLL) & Vaso (OTCMKTS:VASO) - Defense World
Ceribell Receives Authority to Operate from the U.S. Department of Veterans Affairs - Marketscreener.com
CeriBell (NASDAQ:CBLL) Shares Down 2.6%Here's Why - MarketBeat
CeriBell (NASDAQ:CBLL) Receives Consensus Recommendation of "Buy" from Analysts - MarketBeat
Ceribell to Participate in the 43rd Annual J.P. Morgan Healthcare Conference - The Manila Times
Ceribell CEO to Present at J.P. Morgan Healthcare Conference 2025: Medical Tech Innovation in Focus - StockTitan
CeriBell, Inc. Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares - The Eastern Progress Online
CeriBell (NASDAQ:CBLL) Price Target Raised to $33.00 at Canaccord Genuity Group - Defense World
CeriBell (NASDAQ:CBLL) Given New $36.00 Price Target at TD Cowen - Defense World
Ceribell shares PT raised by analyst to reflect higher EV/sales momentum - Investing.com UK
Upstream Bio Leads Life Sciences IPOs With Upsized Listing - MSN
Top 145+ startups in Smart EEG Devices in Nov, 2024 - Tracxn
CeriBell: Healthcare Technology Stock With A Promising Growth Outlook (NASDAQ:CBLL) - Seeking Alpha
Ceribell appoints Rodenbush as CPO, Price as SVP of Marketing - TipRanks
Ceribell Appoints Kristie Rodenbush as Chief People Officer and Brian Price as Senior Vice President of Marketing - The Manila Times
Ceribell Strengthens Leadership Team with Key AI Medical Device Executives | CBLL Stock News - StockTitan
Meet the biophysicist whose seizure-detection company is using AI to get a better read on people's brains - Fast Company
FY2024 EPS Estimates for CeriBell Reduced by William Blair - MarketBeat
William Blair Estimates CeriBell's Q1 Earnings (NASDAQ:CBLL) - MarketBeat
Ceribell revenue increases 48% to USD 17.2M in Q3 2024 - Medical Buyer
Ceribell, Inc. Reports Strong Q3 2024 Growth - Yahoo Finance
Ceribell price target raised to $31 from $30 at Canaccord - TipRanks
1.16%
0.10%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):